Accessibility Menu
 
Recordati Industria Chimica E Farmaceutica S.p.A. logo

Recordati Industria Chimica E Farmaceutica S.p.A.

(OTC) RCDTF

Current Price$56.95
Market Cap$11.65B
Since IPO (2008)+631%
5 Year+25%
1 Year+5%
1 Month-13%

Recordati Industria Chimica E Farmaceutica S.p.A. Financials at a Glance

Market Cap

$11.65B

Revenue (TTM)

$2.55B

Net Income (TTM)

$404.39M

EPS (TTM)

$2.14

P/E Ratio

23.54

Dividend

$1.48

Beta (Volatility)

0.05 (Low)

Price

$56.95

Volume

100

Open

$56.95

Previous Close

$56.95

Daily Range

$56.95 - $56.95

52-Week Range

$49.00 - $65.44

RCDTF News

No articles available.

RCDTF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Recordati Industria Chimica E Farmaceutica S.p.A.

Industry

Pharmaceuticals

Employees

4,583

CEO

Robert Koremans, MD

Headquarters

Milan, MI 20148, IT

RCDTF Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

25%

Net Income Margin

16%

Return on Equity

21%

Return on Capital

15%

Return on Assets

8%

Earnings Yield

4.25%

Dividend Yield

0.03%

Payout Ratio

64.79%

Stock Overview

Market Cap

$11.65B

Shares Outstanding

204.56M

Volume

100

Short Interest

0.00%

Avg. Volume

27.738

Financials (TTM)

Gross Profit

$1.60B

Operating Income

$638.86M

EBITDA

$795.75M

Operating Cash Flow

$569.92M

Capital Expenditure

$851.16M

Free Cash Flow

$281.24M

Cash & ST Invst.

$322.42M

Total Debt

$22.84M

Recordati Industria Chimica E Farmaceutica S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$632.32M

+13.4%

Gross Profit

$432.41M

+12.3%

Gross Margin

68.38%

N/A

Market Cap

$11.65B

N/A

Market Cap/Employee

$2.54M

N/A

Employees

4,580

N/A

Net Income

$110.17M

-2.5%

EBITDA

$219.32M

+4.6%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$142.71M

-32.9%

Accounts Receivable

$699.76M

+38.4%

Inventory

$505.19M

+23.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$328.75M

+902.5%

Return on Assets

7.63%

N/A

Return on Invested Capital

14.84%

N/A

Free Cash Flow

$137.44M

-19.5%

Operating Cash Flow

$152.16M

-18.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHJTFCSPC Pharmaceutical Group Limited
$1.02-12.82%
ORINFOrion Oyj
$78.95+0.00%
BDULFBangkok Dusit Medical Services Public Company Limited
$0.66+0.00%
BDUUFBangkok Dusit Medical Services Public Company Limited
$0.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About RCDTF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.